TABLE IV.
Factor | Survival type | |||||
---|---|---|---|---|---|---|
| ||||||
Progression-free | Overall | |||||
|
|
|||||
HR | 95% CI | p Value | HR | 95% CI | p Value | |
Performance status > 0 | 1.25 | 0.47 to 3.3 | 0.66 | 1.5 | 0.5 to 4.5 | 0.46 |
Liver metastases | 0.52 | 0.16 to 1.67 | 0.27 | 1.12 | 0.27 to 4.55 | 0.88 |
Time from diagnosis of mCRC ≤ 18 months | 0.90 | 0.36 to 2.2 | 0.81 | — | — | — |
Initial dose ≤120 mg | — | — | — | 0.46 | 0.17 to 1.2 | 0.11 |
HR = hazard ratio; CI = confidence interval; mCRC = metastatic colorectal cancer.